NCT00001116View on ClinicalTrials.gov

A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2000

Conditions
HIV Infections
Interventions
DRUG

Tumor Necrosis Factor soluble receptor-immunoadhesin complex

Trial Locations (3)

10016

NY Univ. HIV/AIDS CRS, New York

44106

Case CRS, Cleveland

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH